Both in Pharmaceuticals
Alto Neuroscience vs Kura Oncology
Over the past year ANRO returned +87.0% and KURA returned −4.3%; their daily moves had a correlation of 0.33.
ANRO +87.0% KURA −4.3%Growth of $1, one year, split-adjusted
| Metric | ANRO | KURA |
|---|---|---|
| Price | $22.91 | $10.57 |
| Market cap | $898.8M | $939.9M |
| Today | −1.23% | +6.72% |
| 1 month | −13.8% | −2.2% |
| 6 months | −5.7% | +20.7% |
| Year to date | +28.7% | +1.7% |
| 1 year | +87.0% | −4.3% |
| Revenue growth (YoY) | — | +36.5% |
| Gross margin | — | 98.8% |
| Net margin | — | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 12.2× |
| Net cash | $225.1M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.7% | 54.6% |
| Short % of float | 20.0% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).